Skip to main content

Synthetic Polymer Scaffolds

Biodegradable synthetic polymers are a major class of tissue-engineering scaffolds — designed to provide temporary mechanical support while host cells remodel the construct into native tissue, then resorb.

Polymers in Urologic Tissue Engineering​

  • Polylactide (PLA / PLLA) — lactic-acid polymer; degrades by hydrolysis over months[1]
  • Polybutylene succinate (PBSu) — aliphatic polyester; tunable degradation rate[1]
  • PLA/PBSu blends — combine the mechanical strength of PLA with the flexibility of PBSu[1]
  • Polyglycolic acid (PGA) and poly-lactic-co-glycolic acid (PLGA) — extensively studied in biodegradable scaffolds for multiple tissue-engineering applications
  • Polycaprolactone (PCL) — slower-degrading polyester

Design Considerations​

  • Mechanical properties — matched to the target tissue (urethra, bladder wall, ureter)
  • Degradation rate — slow enough to support tissue formation, fast enough to not impede remodeling
  • Porosity and architecture — promotes cell infiltration and vascularization
  • Biocompatibility — minimal inflammatory response
  • Surface chemistry — supports cell attachment and proliferation

Applications​

  • Urethral tissue engineering — patch and tubularized constructs for stricture reconstruction[1][2]
  • Bladder wall augmentation
  • Ureteral replacement

Current Status​

Investigational. Several groups have produced animal-model and early-human data for urethral tissue-engineered constructs, but no synthetic-polymer scaffold has reached routine clinical adoption.

References​

1. Sartoneva R, Lyyra I, Juusela M, et al. In Vitro Biocompatibility of Polylactide and Polybutylene Succinate Blends for Urethral Tissue Engineering. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 2023;111(10):1728–1740. doi:10.1002/jbm.b.35268

2. Keshel SH, Rahimi A, Hancox Z, et al. The Promise of Regenerative Medicine in the Treatment of Urogenital Disorders. Journal of Biomedical Materials Research. Part A. 2020;108(8):1747–1759. doi:10.1002/jbm.a.36942

See also: Decellularized ECM, Composite Scaffolds.